| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |